tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PTCT Stock Latest News

PTC Therapeutics price target raised to $50 from $44 at Goldman Sachs
The FlyPTC Therapeutics price target raised to $50 from $44 at Goldman Sachs
3d ago
PTCT
PTC Therapeutics’ Earnings Call Highlights Success and Challenges
PremiumCompany Announcements
PTC Therapeutics’ Earnings Call Highlights Success and Challenges
4d ago
PTCT
PTC Therapeutics price target raised to $82 from $70 at RBC Capital
PremiumThe Fly
PTC Therapeutics price target raised to $82 from $70 at RBC Capital
4d ago
PTCT
PTC Therapeutics price target raised to $63 from $50 at TD Cowen
PremiumThe Fly
PTC Therapeutics price target raised to $63 from $50 at TD Cowen
4d ago
PTCT
PTC Therapeutics price target raised to $50 from $44 at Goldman Sachs
PremiumThe Fly
PTC Therapeutics price target raised to $50 from $44 at Goldman Sachs
4d ago
PTCT
PTC Therapeutics price target raised to $80 from $68 at JPMorgan
PremiumThe FlyPTC Therapeutics price target raised to $80 from $68 at JPMorgan
4d ago
PTCT
PTC Therapeutics price target raised to $93 from $73 at Wells Fargo
Premium
The Fly
PTC Therapeutics price target raised to $93 from $73 at Wells Fargo
4d ago
PTCT
PTC Therapeutics price target raised to $68 from $46 at Barclays
Premium
The Fly
PTC Therapeutics price target raised to $68 from $46 at Barclays
4d ago
PTCT
PTC Therapeutics price target raised to $75 from $50 at Citi
PremiumThe Fly
PTC Therapeutics price target raised to $75 from $50 at Citi
4d ago
PTCT
PTC Therapeutics: Strong Market Position and Growth Potential Drive Buy Rating
PremiumRatings
PTC Therapeutics: Strong Market Position and Growth Potential Drive Buy Rating
4d ago
PTCT
PTC Therapeutics: Balancing Sephience Success with DMD Challenges and Strategic Shifts
PremiumRatings
PTC Therapeutics: Balancing Sephience Success with DMD Challenges and Strategic Shifts
5d ago
PTCT
PTC Therapeutics Reports Strong Q3 2025 Results
PremiumCompany Announcements
PTC Therapeutics Reports Strong Q3 2025 Results
5d ago
PTCT
PTC Therapeutics Reports Strong Q3 2025 Financial Results
PremiumCompany AnnouncementsPTC Therapeutics Reports Strong Q3 2025 Financial Results
5d ago
8K
PTCT
PTC Therapeutics reports Q3 EPS 20c, consensus ($1.11)
Premium
The Fly
PTC Therapeutics reports Q3 EPS 20c, consensus ($1.11)
5d ago
PTCT
PTC Therapeutics sees FY25 revenue $750M-$800M, consensus $1.73B
Premium
The Fly
PTC Therapeutics sees FY25 revenue $750M-$800M, consensus $1.73B
5d ago
PTCT
Truist sees no read-throughs to PTC, Wave Life from uniQure news
PremiumThe Fly
Truist sees no read-throughs to PTC, Wave Life from uniQure news
6d ago
WVE
PTCT
PTC Therapeutics price target raised to $77 from $63 at Jefferies
PremiumThe Fly
PTC Therapeutics price target raised to $77 from $63 at Jefferies
12d ago
PTCT
PTCT Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PTCT Upcoming Earnings Report: What to Expect?
19d ago
PTCT
PTC Therapeutics price target raised to $87 from $76 at BofA
PremiumThe Fly
PTC Therapeutics price target raised to $87 from $76 at BofA
20d ago
PTCT
Optimistic Buy Rating for PTC Therapeutics Driven by Strong Demand and Promising Sales Projections for Sephience
PremiumRatingsOptimistic Buy Rating for PTC Therapeutics Driven by Strong Demand and Promising Sales Projections for Sephience
20d ago
PTCT
Strong Buy Rating for PTC Therapeutics Driven by Sephience Launch and Strategic Growth Opportunities
Premium
Ratings
Strong Buy Rating for PTC Therapeutics Driven by Sephience Launch and Strategic Growth Opportunities
25d ago
PTCT
Citizens JMP healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
1M ago
BIIB
DSGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >